Description: The product is a lateral flow chromatographic immunoassay for the qualitative detection of monkeypox virus antigen in human whole blood, serum, plasma or rash exuudate. The kit is intended for professional use only.
Description: A competitive inhibition quantitative ELISA assay kit for detection of 1,5-Anhydroglucitol (1,5-AG) in samples from serum, plasma, tissue homogenates or other biological fluids.
Description: A competitive inhibition quantitative ELISA assay kit for detection of 1,5-Anhydroglucitol (1,5-AG) in samples from serum, plasma, tissue homogenates or other biological fluids.
Description: The Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 is a β -coronavirus, which is an enveloped non-segmented positive-sense RNA virus 2. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have a mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2, fever was the most common symptom, followed by cough3. The main IVD assays used for COVID-19 employ real-time reverse transcriptase-polymerase chain reaction (RT-PCR) that takes a few hours 4. The availability of a cost-effective, rapid point- of-care diagnostic test is critical to enable healthcare professionals to aid in the diagnosis of patients and prevent further spread of the virus5. Antigen tests will play a critical role in the fight against COVID-19
Description: AG18 is an inhibitor of EGFR kinase with IC50 values of 35?M. [3]AG18 acts as general tyrosine kinase inhibitor to block tyrosine phosphorylation and events downstream of tyrosine phosphorylation.
Description: AG18 is an inhibitor of EGFR kinase with IC50 values of 35?M. [3]AG18 acts as general tyrosine kinase inhibitor to block tyrosine phosphorylation and events downstream of tyrosine phosphorylation.
Description: AG18 is an inhibitor of EGFR kinase with IC50 values of 35?M. [3]AG18 acts as general tyrosine kinase inhibitor to block tyrosine phosphorylation and events downstream of tyrosine phosphorylation.
Description: AG1024 is an inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR) that specifically inhibits autophosphorylation of IGF-1R and IR with IC50 values of 7?M and 57 ?m, respectively [1].
Description: AG1024 is an inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR) that specifically inhibits autophosphorylation of IGF-1R and IR with IC50 values of 7?M and 57 ?m, respectively [1].
Description: AG1024 is an inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR) that specifically inhibits autophosphorylation of IGF-1R and IR with IC50 values of 7?M and 57 ?m, respectively [1].
Description: AG1024 is an inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR) that specifically inhibits autophosphorylation of IGF-1R and IR with IC50 values of 7?M and 57 ?m, respectively [1].
Description: AG 99 is a potent inhibitor of EGF receptor tyrosine kinase with IC50 value of 10 ?M [1]. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation.
Description: AG 99 is a potent inhibitor of EGF receptor tyrosine kinase with IC50 value of 10 ?M [1]. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation.
Description: AG 99 is a potent inhibitor of EGF receptor tyrosine kinase with IC50 value of 10 ?M [1]. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation.
Description: AG 556 is a selective inhibitor of EGFR with IC50 value of 1.1 ?M. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation.
Description: AG 556 is a selective inhibitor of EGFR with IC50 value of 1.1 ?M. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation.
Description: AG 555 is a potent and selective inhibitor of EGFR with IC50 value of 0.7 ?M. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation.
Description: AG 555 is a potent and selective inhibitor of EGFR with IC50 value of 0.7 ?M. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation.
Description: AG 555 is a potent and selective inhibitor of EGFR with IC50 value of 0.7 ?M. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation.
Description: AG 494 is a potent and selective inhibitor of EGFR with IC50 value of 0.7 ?M. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation.
Description: AG 494 is a potent and selective inhibitor of EGFR with IC50 value of 0.7 ?M. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation.
Description: AG 494 is a potent and selective inhibitor of EGFR with IC50 value of 0.7 ?M. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation.
Description: AG-490 is an inhibitor of tyrosine kinases [1].As a member of the tyrphostin family, AG-490 is reported to have inhibitory activity against many kinases.
Description: AG-490 is an inhibitor of tyrosine kinases [1].As a member of the tyrphostin family, AG-490 is reported to have inhibitory activity against many kinases.
Description: AG-490 is an inhibitor of tyrosine kinases [1].As a member of the tyrphostin family, AG-490 is reported to have inhibitory activity against many kinases.
Description: AG-14361 is a selective inhibitor of PARP-1 with Ki50 valuePARP1 is a member of PRAP family and plays an important role in many cellular processes, such as DNA repair, programmed cell death.
Description: AG-14361 is a selective inhibitor of PARP-1 with Ki50 valuePARP1 is a member of PRAP family and plays an important role in many cellular processes, such as DNA repair, programmed cell death.
Description: AG-14361 is a selective inhibitor of PARP-1 with Ki50 valuePARP1 is a member of PRAP family and plays an important role in many cellular processes, such as DNA repair, programmed cell death.
Description: AG-14361 is a selective inhibitor of PARP-1 with Ki50 valuePARP1 is a member of PRAP family and plays an important role in many cellular processes, such as DNA repair, programmed cell death.
Description: AG-14361 is a selective inhibitor of PARP-1 with Ki50 valuePARP1 is a member of PRAP family and plays an important role in many cellular processes, such as DNA repair, programmed cell death.
Description: AG 045572, also called CMPD1, is a nonpeptidic antagonist of gonadotropin-releasing hormone (GnRH) [1], with Ki values of 6.0 nM and 2.2nM to human and mouse GnRH receptors, respectively [2].
Description: AG 045572, also called CMPD1, is a nonpeptidic antagonist of gonadotropin-releasing hormone (GnRH) [1], with Ki values of 6.0 nM and 2.2nM to human and mouse GnRH receptors, respectively [2].
Description: IC50: < 100 nMAG-120 is an IDH1 inhibitor.Isocitrate dehydrogenase (IDH) is a metabolic enzyme interconverting isocitrate and ?-ketoglutarate (?-KG), but cancer-associated mutations of IDH1 and IDH2 confer a neomorphic activity, which allows reduction of ?-KG to the oncometabolite 2-HG.
Description: IC50: < 100 nMAG-120 is an IDH1 inhibitor.Isocitrate dehydrogenase (IDH) is a metabolic enzyme interconverting isocitrate and ?-ketoglutarate (?-KG), but cancer-associated mutations of IDH1 and IDH2 confer a neomorphic activity, which allows reduction of ?-KG to the oncometabolite 2-HG.
Description: pIC50: 8.194AG-1557 is an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase.The epidermal growth factor receptor (EGFR) is a member of the receptor family of tyrosine kinases.
Description: pIC50: 8.194AG-1557 is an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase.The epidermal growth factor receptor (EGFR) is a member of the receptor family of tyrosine kinases.
Description: pIC50: 8.194AG-1557 is an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase.The epidermal growth factor receptor (EGFR) is a member of the receptor family of tyrosine kinases.
Description: pIC50: 8.194AG-1557 is an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase.The epidermal growth factor receptor (EGFR) is a member of the receptor family of tyrosine kinases.
Description: IC50: 0.3-1 ?M for PDGF receptor kinase in vitro and in Swiss 3T3 cells AG-1295 is a potent and selective inhibitor of PDGF receptor kinase. Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs.
Description: IC50: 0.3-1 ?M for PDGF receptor kinase in vitro and in Swiss 3T3 cells AG-1295 is a potent and selective inhibitor of PDGF receptor kinase. Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs.
Description: IC50: 0.3-1 ?M for PDGF receptor kinase in vitro and in Swiss 3T3 cells AG-1295 is a potent and selective inhibitor of PDGF receptor kinase. Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs.
Description: IC50: 20 ?M for PDGF receptor kinase in human bone marrow fibroblastsAG-370 is a tyrphostin PDGFR inhibitor. Protein tyrosine kinase inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of protein tyrosine kinases.
Description: IC50: 20 ?M for PDGF receptor kinase in human bone marrow fibroblastsAG-370 is a tyrphostin PDGFR inhibitor. Protein tyrosine kinase inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of protein tyrosine kinases.
Description: IC50: 20 ?M for PDGF receptor kinase in human bone marrow fibroblastsAG-370 is a tyrphostin PDGFR inhibitor. Protein tyrosine kinase inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of protein tyrosine kinases.
Description: IC50: 20 ?M for PDGF receptor kinase in human bone marrow fibroblastsAG-370 is a tyrphostin PDGFR inhibitor. Protein tyrosine kinase inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of protein tyrosine kinases.
Description: AG-82 is a cell-permeable, reversible, and competitive inhibitor of tyrosine kinase and epidermal growth factor (EGF) receptor.Protein tyrosine kinases (PTKs) have been involved in regulating cell proliferation, cell differentiation, and signaling processes in the immune system.
Description: AG-82 is a cell-permeable, reversible, and competitive inhibitor of tyrosine kinase and epidermal growth factor (EGF) receptor.Protein tyrosine kinases (PTKs) have been involved in regulating cell proliferation, cell differentiation, and signaling processes in the immune system.
Description: AG-213 is an inhibitor of protein tyrosine kinases (PTKs) and epidermal growth factor (EGF) receptor kinase [1,2].Protein tyrosine kinases (PTKs) have been involved in regulating cell proliferation, cell differentiation, and signaling processes in the immune system.
Description: AG-213 is an inhibitor of protein tyrosine kinases (PTKs) and epidermal growth factor (EGF) receptor kinase [1,2].Protein tyrosine kinases (PTKs) have been involved in regulating cell proliferation, cell differentiation, and signaling processes in the immune system.
Description: AG-213 is an inhibitor of protein tyrosine kinases (PTKs) and epidermal growth factor (EGF) receptor kinase [1,2].Protein tyrosine kinases (PTKs) have been involved in regulating cell proliferation, cell differentiation, and signaling processes in the immune system.
Description: AG-213 is an inhibitor of protein tyrosine kinases (PTKs) and epidermal growth factor (EGF) receptor kinase [1,2].Protein tyrosine kinases (PTKs) have been involved in regulating cell proliferation, cell differentiation, and signaling processes in the immune system.
Description: AG-183, a member of tyrphostin, is an inhibitor of protein tyrosine kinase [1]. Protein tyrosine kinase is an enzyme that catalyzes the transfer of the ? phosphate of ATP to tyrosine residues on protein substrates.
Description: AG-183, a member of tyrphostin, is an inhibitor of protein tyrosine kinase [1]. Protein tyrosine kinase is an enzyme that catalyzes the transfer of the ? phosphate of ATP to tyrosine residues on protein substrates.
Description: AG-183, a member of tyrphostin, is an inhibitor of protein tyrosine kinase [1]. Protein tyrosine kinase is an enzyme that catalyzes the transfer of the ? phosphate of ATP to tyrosine residues on protein substrates.
Description: AG-1478 is an inhibitor of EGFR which acts on EGF-stimulated Erk1/2 phosphorylation with IC50 value of 10 uM using ovarian cell line Ishikawa [1].
Description: AG-1478 is an inhibitor of EGFR which acts on EGF-stimulated Erk1/2 phosphorylation with IC50 value of 10 uM using ovarian cell line Ishikawa [1].
Description: AG-1478 is an inhibitor of EGFR which acts on EGF-stimulated Erk1/2 phosphorylation with IC50 value of 10 uM using ovarian cell line Ishikawa [1].
Description: AG-1478 is an inhibitor of EGFR which acts on EGF-stimulated Erk1/2 phosphorylation with IC50 value of 10 uM using ovarian cell line Ishikawa [1].
Did not find what you were looking for? Send us request and we will contact with you!
This website uses cookies to improve your experience. We'll assume you're ok with this. More InformationClose
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
)
 ELISA Kit)
)
 ELISA Kit)
